Invention Grant
- Patent Title: Antibodies against HPA-1a
-
Application No.: US15300656Application Date: 2015-03-31
-
Publication No.: US10882919B2Publication Date: 2021-01-05
- Inventor: Terje Michaelsen , Oistein Ihle , Tor Brynjar Stuge , Anne Husebekk , Heidi Tiller , Mariana Eksteen , Bjorn Ragnar Skogen
- Applicant: Rallybio IPA, LLC
- Applicant Address: US CT Farmington
- Assignee: Rallybio IPA, LLC
- Current Assignee: Rallybio IPA, LLC
- Current Assignee Address: US CT Farmington
- Agency: Grimes & Yvon LLP
- Priority: GB1405775.6 20140331,GB1417614.3 20141006
- International Application: PCT/EP2015/057102 WO 20150331
- International Announcement: WO2015/150417 WO 20151008
- Main IPC: C07K16/34
- IPC: C07K16/34 ; C07K16/28 ; G01N33/68
Abstract:
The present invention provides an isolated antibody that specifically binds to HPA-1a. Also provided is a nucleic acid molecule that encodes the antibody, and compositions comprising the antibody. Also provided is a method of producing the antibody and methods and uses which employ the antibody. Also provided are therapeutic uses of the antibody, for example in the treatment or prophylaxis of fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Public/Granted literature
- US20170121422A1 ANTIBODIES AGAINST HPA-1A Public/Granted day:2017-05-04
Information query
